chevron_leftBack
As of 9 June 2026, Hainan Poly Pharm. Co., Ltd. has a market cap of $73.3M USD, ranking #27770 globally and #6005 in China.
It ranks #2499 in the Healthcare sector, and #135 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$73.3MUSD
496.69M CNY
Enterprise Value
$426.07MUSD
2.88B CNY
Revenue (TTM)
$192.81MUSD
1.31B CNY
EBITDA (TTM)
$24.47MUSD
165.6M CNY
Net Income (TTM)
-$15.65MUSD
-106.04M CNY
EBITDA Margin
13%
Profit Margin
-8.1%
PS Ratio
0.4
PB Ratio
0.2
EV/EBITDA
17.3
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Min Hua Fan
open_in_new
Employees
1,565
Founded
1992
Website
hnpoly.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.1% | -1.1% | -65% | -66% | -92% | -93% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300630
海南普利制药股份有限公司 Class A
ISIN: CNE100002N10
Shares Out.:
Shares Outstanding:
333.246M1
Shares Float:
253.912M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.8900 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hainan Poly Pharm. Co., Ltd.
Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company’s dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, excipients, prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was founded in 1992 and is headquartered in Haikou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.84B
22K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.09B
12K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.21B
7K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.2B
6K%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.26B
4K%
22.12B CNY
|
8.1
|
|
|
$2.74B
4K%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.17B
51K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
40K%
|
-
|
|
NSE: CIPLA
|
$11.16B
15K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
15K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.72B
12K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.46B
11K%
807.02B INR
|
23.1
|
chevron_leftBack